AMZN
Amazon.com, Inc.
AMZN has the edge over RH overall, supported by lower modeled downside and stronger modeled upside.
RH
Rh
RH's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
RH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
RH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over RH in the historical PE scenario, which offers more potential upside but is not a forecast.
RH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $80.52 | -38% |
| Forward | 17x | $129 | — |
| Current | 23x | $129 | — |
| Fair | 31x | $174 | +35% |
| Expensive | 59x | $332 | +157% |
Historical ranges are pointers, not guarantees.
RH's PE is in its cheap range at 23x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
RH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
RH has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over RH on earnings, with more consistent year-over-year improvement.
RH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.76 | +38% |
| Q3 2026 | $5.62 | +4.3% |
| Q2 2026 | $5.18 | +23% |
| Q1 2026 | $6.31 | +74% |
| Q4 2025 | $5.56 | +46% |
| Q3 2025 | $5.39 | +164% |
| Q2 2025 | $4.22 | +6.8% |
| Q1 2025 | $3.62 | -39% |
| Q4 2024 | $3.82 | -59% |
RH's earnings per share have fallen from their peak: $5.62 over the past year, against $25.16 in early 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over RH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over RH on profitability, with a higher operating margin.
RH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $922.2M | +2.6% |
| Q2 2026 | $800.3M | -1.7% |
| Q1 2026 | $842.6M | +3.7% |
| Q4 2025 | $883.8M | +8.9% |
| Q3 2025 | $899.2M | +8.4% |
| Q2 2025 | $814M | +12% |
| Q4 2024 | $811.7M | +8.1% |
| Q3 2024 | $829.7M | +3.6% |
RH's revenue has held roughly level: $922M last quarter, up 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -2.7 points |
| Q2 2026 | 4.3% | -2.6 points |
| Q1 2026 | 11% | +2.8 points |
| Q4 2025 | 12% | -0.5 points |
| Q3 2025 | 14% | +2.7 points |
| Q2 2025 | 6.9% | -0.6 points |
| Q1 2025 | 8.7% | N/A |
| Q4 2024 | 13% | +5.7 points |
RH's operating margin was 12% last quarter, down 2.7 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
RH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $99.6M | +23% |
| Q2 2026 | $13.3M | -61% |
| Q1 2026 | $54.6M | +$124.3M |
| Q4 2025 | $83M | +$179M |
| Q3 2025 | $80.7M | +$118.6M |
| Q2 2025 | $34.1M | +$44.2M |
| Q1 2025 | -$69.7M | +$181.8M |
| Q4 2024 | -$96M | -646% |
RH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
RH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.4% | +824K shares |
| 1 year | -0.3% | -68K shares |
| 3 years | -13% | -3.1M shares |
| 5 years | -37% | -11.5M shares |
| Available history | -19% | -4.5M shares |
RH has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q1 2024 | — |
| Q4 2023 | $44.6M |
| Q1 2023 | $713.6M |
| Q4 2022 | $31.7M |
| Q1 2020 | — |
| Q4 2019 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
RH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.2x | Very low |
RH has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
RH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.3 | Neutral |
| Stochastic | 30.5 | Neutral |
RH's weekly RSI is 44 (neutral) and its Stochastic is 30 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over RH on valuation relative to its sector.
RH PE vs Consumer Cyclical Sector
| Metric | RH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 28% above |
| PE % | 32 | 47 | 15 pts below |
RH is trading at 23x earnings, a 28% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over RH on trend strength, trading above more of its moving averages.
RH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $127.4 | 1.4% above |
| 20 week MA | $148.5 | 13% below |
| 50 week MA | $156.8 | 18% below |
| 100 week MA | $198.9 | 35% below |
| 200 week MA | $243.8 | 47% below |
RH has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 47% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over RH on returns for 2026, with the stronger performance.
RH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $214.9 | $475.7 | +121% |
| 2021 | $475.7 | $546.1 | +15% |
| 2022 | $546.1 | $264.4 | -52% |
| 2023 | $264.4 | $291.5 | +10% |
| 2024 | $291.5 | $398.1 | +37% |
| 2025 | $398.1 | $185.7 | -53% |
| 2026 YTD | $185.7 | $129.2 | -30% |
RH's yearly returns have swung widely, from +121% in 2020 to −53% in 2025. It's down 30% so far in 2026.